US1044508A
(en)
*
|
1911-04-21 |
1912-11-19 |
Ajax Forge Company |
Railway-frog.
|
BE789948A
(fr)
|
1971-10-13 |
1973-04-11 |
Sandoz Sa |
Nouveaux derives du pyrazole, leur preparation et leur application comme medicaments
|
JPS5113156B2
(ru)
|
1972-10-21 |
1976-04-26 |
|
|
US4016037A
(en)
|
1975-10-15 |
1977-04-05 |
Ajinomoto Co., Inc. |
Method for producing L-amino acid
|
US4110536A
(en)
|
1977-04-18 |
1978-08-29 |
Miles Laboratories, Inc. |
Derivatives of 5-(indol-3-yl)hydantoin
|
DE2728523C2
(de)
|
1977-06-23 |
1986-02-27 |
Schering AG, 1000 Berlin und 4709 Bergkamen |
4-Methyl-1,2,3-thiadiazol-5-carbonsäure-(cyclohexylmethyl)-amid, Mittel mit herbizider und wachstumsregulatorischer Wirkung enthaltend diese Verbindung sowie Verfahren zu seiner Herstellung
|
JPS55136279A
(en)
*
|
1979-04-09 |
1980-10-23 |
Ajinomoto Co Inc |
Preparation of tryptophan hydantoin
|
JPS5810074B2
(ja)
|
1979-07-18 |
1983-02-24 |
味の素株式会社 |
新規微生物
|
SG56656G
(en)
|
1980-07-28 |
1987-03-27 |
Pfizer |
Hypoglycemic 5-substituted oxazolidine-2, 4-diones
|
US4332952A
(en)
|
1980-07-28 |
1982-06-01 |
Pfizer Inc. |
Hypoglycemic 5-substituted oxazolidine-2,4-diones
|
EP0164247B1
(en)
|
1984-06-07 |
1989-01-11 |
Pfizer Limited |
Dihydropyridines
|
JPS6122081A
(ja)
|
1984-07-10 |
1986-01-30 |
Mitsui Toatsu Chem Inc |
ヒダントイン化合物の製造法
|
US4684735A
(en)
|
1985-07-01 |
1987-08-04 |
Stauffer Chemical Company |
Promotion of raney nickel hydrogenation catalyst
|
JPH0623148B2
(ja)
|
1985-09-05 |
1994-03-30 |
三井東圧化学株式会社 |
N−アセチル−dl−アミノ酸の製造方法
|
DE3685626T2
(de)
|
1985-09-26 |
1993-01-28 |
Beckmann Research Inst Of The |
Sequenzierung von peptiden.
|
JPH0659227B2
(ja)
|
1985-11-08 |
1994-08-10 |
三井東圧化学株式会社 |
D−α−アミノ酸の製造方法
|
JPS6225990A
(ja)
|
1986-07-19 |
1987-02-03 |
Kanegafuchi Chem Ind Co Ltd |
D−α−アミノ酸類の製造方法
|
US4705864A
(en)
|
1986-11-10 |
1987-11-10 |
The Standard Oil Company |
Aryl oxime derivatives of hydantoins
|
US4911931A
(en)
|
1987-08-03 |
1990-03-27 |
Baylink David J |
Pharmaceutical combination for treatment of bone-wasting diseases
|
JP2661111B2
(ja)
|
1988-03-09 |
1997-10-08 |
三菱化学株式会社 |
D−N−カルバミル−α−アミノ酸の製造法
|
US4868061A
(en)
|
1988-05-19 |
1989-09-19 |
The Standard Oil Company |
Olefinic aryl oxime derivatives of hydantoins
|
IE62214B1
(en)
|
1988-05-25 |
1995-01-11 |
Warner Lambert Co |
Arylmethylenyl derivatives of thiazolidinones, imidazolidinones and oxazolidinones useful as antiallergy agents and antiinflammatory agents
|
JPH0219363A
(ja)
|
1988-07-06 |
1990-01-23 |
Fujisawa Pharmaceut Co Ltd |
イミダゾリジン誘導体
|
WO1990004183A1
(en)
|
1988-10-07 |
1990-04-19 |
Commonwealth Scientific And Industrial Research Organisation |
Method for preparation of thiohydantoins and for protein sequence analysis
|
DE58905691D1
(de)
|
1989-01-02 |
1993-10-28 |
Ruetgerswerke Ag |
Verfahren zur Herstellung von L-alpha-Aminosäuren.
|
JPH054910A
(ja)
|
1990-07-31 |
1993-01-14 |
Nikka Chem Co Ltd |
化粧料組成物
|
NZ239595A
(en)
|
1990-08-31 |
1994-06-27 |
Warner Lambert Co |
Cholecystokinin antagonistic compounds ; pharmaceutical compositions and use thereof
|
JP2651755B2
(ja)
|
1991-03-01 |
1997-09-10 |
富士写真フイルム株式会社 |
ハロゲン化銀カラー写真感光材料
|
NZ286242A
(en)
|
1991-03-26 |
1997-11-24 |
Csl Ltd |
Use of veterinary implant as a single dose vaccination system: rupturable polymer film coating around core of active agent and water soluble excipient
|
US5693643A
(en)
|
1991-09-16 |
1997-12-02 |
Merck & Co., Inc. |
Hydantoin and succinimide-substituted derivatives of spiroindanylcamphorsulfonyl oxytocin antagonists
|
EP0533243B1
(en)
|
1991-09-16 |
1997-12-17 |
Merck & Co. Inc. |
Hydantoin and succinimide-substituted spiroindanylcamphorsulfonyl derivatives
|
EP0545478A1
(en)
|
1991-12-03 |
1993-06-09 |
MERCK SHARP & DOHME LTD. |
Heterocyclic compounds as tachykinin antagonists
|
JP3163361B2
(ja)
|
1992-03-12 |
2001-05-08 |
味の素株式会社 |
5−アルキルヒダントイン誘導体の製造法
|
DE69320730T2
(de)
|
1992-07-14 |
1999-02-11 |
Nippon Chemiphar Co. Ltd., Tokio/Tokyo |
Alkylendiaminderivate
|
US5574030A
(en)
|
1992-07-14 |
1996-11-12 |
Nippon Chemiphar Co., Ltd. |
N-aminoalkyl-substituted nitrogen-containing five membered heterocyclic compounds
|
US5830854A
(en)
|
1992-12-14 |
1998-11-03 |
Merck Sharp & Dohme, Limited |
Method of treating cystic fibrosis using a tachykinin receptor antagonist
|
US5338859A
(en)
|
1993-02-12 |
1994-08-16 |
Hoechst Celanese Corporation |
Process for the production of calcium salts of hydantoic acids
|
EP0640594A1
(en)
|
1993-08-23 |
1995-03-01 |
Fujirebio Inc. |
Hydantoin derivative as metalloprotease inhibitor
|
AU701863B2
(en)
|
1994-09-08 |
1999-02-04 |
Eli Lilly And Company |
Excitatory amino acid receptor antagonists
|
AU4424496A
(en)
|
1995-03-27 |
1996-10-16 |
Warner-Lambert Company |
A method for the synthesis of mixtures of compounds
|
US6166054A
(en)
|
1995-03-31 |
2000-12-26 |
Nihon Nohyaku Co., Ltd. |
Agricultural and horticultural disease controller and a method for controlling the diseases
|
US5674734A
(en)
|
1995-05-18 |
1997-10-07 |
President And Fellows Of Harvard College |
Cell death protein
|
DE19519717C1
(de)
|
1995-05-30 |
1996-08-22 |
Degussa |
Neuer Mikroorganismus, dessen Verwendung und Verfahren zur Herstellung von L-alpha-Aminosäuren
|
US6846839B1
(en)
|
1995-06-07 |
2005-01-25 |
Sugen, Inc. |
Methods for treating diseases and disorders related to unregulated angiogenesis and/or vasculogenesis
|
US5962478A
(en)
|
1995-09-19 |
1999-10-05 |
Margolin; Solomon B. |
Inhibition of tumor necrosis factor α
|
WO1997015586A1
(en)
|
1995-10-23 |
1997-05-01 |
Tularik, Inc. |
Rip: novel human protein involved in tumor necrosis factor signal transduction, and screening assays
|
CN1127488C
(zh)
|
1996-04-24 |
2003-11-12 |
诺沃挪第克公司 |
具有生长激素释放特性的化合物
|
CN1072657C
(zh)
|
1996-09-30 |
2001-10-10 |
日本农药株式会社 |
1,2,3-噻二唑衍生物和其盐以及农业园艺病毒防治剂及其使用方法
|
US5859190A
(en)
|
1997-02-04 |
1999-01-12 |
Trega Biosciences, Inc. |
Combinatorial libraries of hydantoin and thiohydantoin derivatives, methods of making the libraries and compounds therein
|
WO1998039303A1
(en)
|
1997-03-03 |
1998-09-11 |
Boehringer Ingelheim Pharmaceuticals, Inc. |
Small molecules useful in the treatment of inflammatory disease
|
IL126024A0
(en)
|
1998-03-19 |
1999-05-09 |
Yeda Res & Dev |
Modulators of the function of receptors of the tnf/ngf receptor family and other proteins
|
ATE238661T1
(de)
|
1998-07-30 |
2003-05-15 |
Nihon Nohyaku Co Ltd |
Fungizide zusammensetzung enthaltend ein 1,2,3- thiadiazolderivat sowie deren verwendung
|
DE19940211A1
(de)
|
1998-09-22 |
2000-03-23 |
Degussa |
Verfahren zur Herstellung von Imidazolidin-2,4-dionen
|
US6020198A
(en)
|
1998-09-25 |
2000-02-01 |
Isis Pharmaceuticals Inc. |
Antisense modulation of RIP-1 expression
|
AU754989B2
(en)
|
1998-11-16 |
2002-11-28 |
Nippon Zoki Pharmaceutical Co., Ltd. |
A therapeutic agent for intractable vasculitis
|
WO2001007044A1
(en)
|
1999-07-21 |
2001-02-01 |
Boehringer Ingelheim Pharmaceuticals, Inc. |
Small molecules useful in the treatment of inflammatory disease
|
US6350763B1
(en)
|
1999-07-21 |
2002-02-26 |
Boehringer Ingelheim Pharmaceuticals, Inc. |
Small molecules useful in the treatment of inflammation disease
|
WO2001028493A2
(en)
|
1999-10-15 |
2001-04-26 |
President And Fellows Of Harvard College |
Small molecule inhibitors of necrosis
|
US6756394B1
(en)
|
1999-10-15 |
2004-06-29 |
President And Fellow Of Harvard College |
Small molecule inhibitors of necrosis
|
US6706766B2
(en)
|
1999-12-13 |
2004-03-16 |
President And Fellows Of Harvard College |
Small molecules used to increase cell death
|
AU2001244596A1
(en)
|
2000-03-30 |
2001-10-15 |
Rei Asakai |
Indolylpyrrole derivatives and cell death inhibitors
|
US20020155172A1
(en)
|
2000-04-07 |
2002-10-24 |
Junying Yuan |
Methods and compounds for decreasing cell toxicity or death
|
GB0011071D0
(en)
|
2000-05-08 |
2000-06-28 |
Novartis Ag |
Organic compounds
|
US6846643B2
(en)
|
2000-08-14 |
2005-01-25 |
Boehringer Ingelheim Pharmaceuticals, Inc. |
Methods and molecules useful for identifying molecules that bind LFA-1 and for determining receptor occupancy
|
US20020064736A1
(en)
|
2000-09-27 |
2002-05-30 |
Fuji Photo Film Co., Ltd. |
Dye-forming coupler, silver halide photographic light-sensitive material, and method for producing an azomethine dye
|
JP2002145192A
(ja)
|
2000-11-07 |
2002-05-22 |
Yamaha Motor Co Ltd |
水上乗物の燃料タンク構造
|
JP4529338B2
(ja)
|
2001-03-08 |
2010-08-25 |
味の素株式会社 |
ヒダントイナーゼをコードするdna、n−カルバミル−l−アミノ酸ハイドロラーゼをコードするdna、組み換えdna、形質転換された細胞、タンパク質の製造方法および光学活性アミノ酸の製造方法
|
CA2460541A1
(en)
|
2001-09-14 |
2003-04-03 |
Helle Birk Olsen |
Novel ligands for the hisb10 zn2+ sites of the r-state insulin hexamer
|
US20040019092A1
(en)
|
2001-11-14 |
2004-01-29 |
Daniel Berney |
Non-peptide somatostatin receptor ligands
|
KR20050044581A
(ko)
|
2001-11-22 |
2005-05-12 |
오노 야꾸힝 고교 가부시키가이샤 |
피페리딘-2-온 유도체 화합물 및 그 화합물을 유효성분으로서 함유하는 약제
|
US6797708B2
(en)
|
2001-12-03 |
2004-09-28 |
Wyeth |
Inhibitors of cytosolic phospholipase A2
|
JP3659224B2
(ja)
|
2001-12-26 |
2005-06-15 |
村田機械株式会社 |
インターネットファクシミリ装置
|
WO2003057214A1
(en)
|
2001-12-28 |
2003-07-17 |
Somatocor Pharmaceuticals, Inc. |
Imidazolidin-2,4-dione derivatives as non-peptide somatostatin receptor ligands
|
WO2003068914A2
(en)
|
2002-02-11 |
2003-08-21 |
Wyeth |
Solution structure of rip dd and uses therof
|
US20060099645A1
(en)
|
2002-09-06 |
2006-05-11 |
Mount Sinai Hospital |
Methods and reagents for assaying molecular interactions
|
JP2006517092A
(ja)
|
2002-11-27 |
2006-07-20 |
アルテシアン セラピューティック,インコーポレイティド |
心不全遺伝子の決定及び治療薬スクリーニング
|
ES2297227T3
(es)
|
2002-12-20 |
2008-05-01 |
Novo Nordisk A/S |
Composiciones farmaceuticas conteniendo insulina y ligandos del hexamero de insulina.
|
FR2850652B1
(fr)
|
2003-01-31 |
2008-05-30 |
Aventis Pharma Sa |
Nouveaux derives d'uree cyclique, leur preparation et leur utilisation pharmaceutique comme inhibiteurs de kinases
|
GB0302671D0
(en)
|
2003-02-06 |
2003-03-12 |
Astrazeneca Ab |
Pharmaceutical formulations
|
US7320986B2
(en)
|
2003-03-07 |
2008-01-22 |
Abbott Labortories |
Fused tri and tetra-cyclic pyrazole kinase inhibitors
|
EP1610812A1
(en)
|
2003-03-11 |
2006-01-04 |
Novo Nordisk A/S |
Pharmaceutical preparations comprising acid-stabilised insulin
|
EP1605967A1
(en)
|
2003-03-13 |
2005-12-21 |
Novo Nordisk A/S |
Novel nph insulin preparations
|
JP2007504171A
(ja)
|
2003-08-29 |
2007-03-01 |
ザ ブライハム アンド ウイメンズ ホスピタル, インコーポレイテッド |
細胞壊死インヒビター
|
JP4452914B2
(ja)
|
2003-09-08 |
2010-04-21 |
味の素株式会社 |
新規トランスポータタンパク質
|
DE10342839A1
(de)
|
2003-09-17 |
2005-04-28 |
Symrise Gmbh & Co Kg |
Thiohydantoine zur Aufhellung von Haut oder Haar
|
US20080019909A1
(en)
|
2003-09-17 |
2008-01-24 |
Francis Ka-Ming Chan |
Modulation of Programmed Necrosis
|
US6887993B1
(en)
|
2003-11-12 |
2005-05-03 |
Kosan Biosciences, Inc. |
11-O-methylgeldanamycin compounds
|
WO2005080372A1
(en)
|
2004-02-19 |
2005-09-01 |
Bayer Healthcare Ag |
Dihydropyridinone derivatives
|
US7935510B2
(en)
|
2004-04-30 |
2011-05-03 |
Intrexon Corporation |
Mutant receptors and their use in a nuclear receptor-based inducible gene expression system
|
GB0410379D0
(en)
|
2004-05-11 |
2004-06-16 |
Univ Leicester |
Treatment of cancer
|
PT1773768T
(pt)
|
2004-07-30 |
2018-11-30 |
Exelixis Inc |
Derivados de pirrol como agentes farmacêuticos
|
JP2008530094A
(ja)
|
2005-02-10 |
2008-08-07 |
メルク エンド カムパニー インコーポレーテッド |
有糸分裂キネシン阻害剤
|
WO2006103995A1
(ja)
|
2005-03-25 |
2006-10-05 |
Kaneka Corporation |
光学活性α-アミノ酸誘導体の製造方法
|
KR20080039982A
(ko)
|
2005-08-25 |
2008-05-07 |
쉐링 코포레이션 |
작용 선택적 알파2c 아드레날린성 수용체 효능제로서의이미다졸 유도체
|
JP2009513576A
(ja)
*
|
2005-10-11 |
2009-04-02 |
インターミューン・インコーポレーテッド |
ウィルス複製のインヒビター
|
CA2628259A1
(en)
|
2005-11-01 |
2007-05-10 |
Janssen Pharmaceutica N.V. |
Dihydroisoindolones as allosteric modulators of glucokinase
|
CN101674826A
(zh)
|
2005-12-20 |
2010-03-17 |
哈佛大学校长及研究员协会 |
化合物、筛选和治疗方法
|
AR056882A1
(es)
|
2006-02-01 |
2007-10-31 |
Bayer Cropscience Sa |
Derivados del fungicida n- cicloalquil- bencil- amida
|
US8007790B2
(en)
|
2006-04-03 |
2011-08-30 |
Stowers Institute For Medical Research |
Methods for treating polycystic kidney disease (PKD) or other cyst forming diseases
|
US20100104659A1
(en)
|
2006-07-13 |
2010-04-29 |
Matthias Vennemann |
Benzopyranopyrazoles
|
AU2007307044B2
(en)
|
2006-10-10 |
2014-03-20 |
President And Fellows Of Harvard College |
Compounds, screens, and methods of treatment
|
US8420683B2
(en)
*
|
2007-06-06 |
2013-04-16 |
Dsm Sinochem Pharmaceuticals Netherlands B.V. |
5 substituted hydantoins
|
JP5645663B2
(ja)
|
2007-08-15 |
2014-12-24 |
プレジデント アンド フェローズ オブ ハーバード カレッジ |
ネクロトーシスのヘテロ環式抑制剤
|
EP2543368A1
(en)
|
2007-12-11 |
2013-01-09 |
Viamet Pharmaceuticals, Inc. |
Metalloenzyme inhibitors using metal binding moieties in combination with targeting moieties
|
JP2011512132A
(ja)
|
2008-02-14 |
2011-04-21 |
エフ.ホフマン−ラ ロシュ アーゲー |
骨髄毒性の予測方法
|
US20120061324A1
(en)
*
|
2008-03-28 |
2012-03-15 |
Global Material Technologies, Inc. |
Element removal process and apparatus
|
US8304421B2
(en)
|
2008-09-30 |
2012-11-06 |
Vanderbilt University |
Indole compounds and their use as radiation sensitizing agents and chemotherapeutic agents
|
WO2010075290A1
(en)
|
2008-12-22 |
2010-07-01 |
President And Fellows Of Harvard College |
Unsaturated heterocyclic inhibitors of necroptosis
|
US20120122889A1
(en)
|
2008-12-23 |
2012-05-17 |
President And Fellows Of Harvard College |
Small molecule inhibitors of necroptosis
|
JP2010202575A
(ja)
|
2009-03-03 |
2010-09-16 |
Takeda Chem Ind Ltd |
複素環化合物
|
DE102009002044A1
(de)
|
2009-03-31 |
2010-10-07 |
Evonik Degussa Gmbh |
Dipeptide als Futtermitteladditive
|
JP5332882B2
(ja)
|
2009-04-30 |
2013-11-06 |
豊田合成株式会社 |
半導体発光素子
|
JP2010275229A
(ja)
|
2009-05-28 |
2010-12-09 |
Ikutoku Gakuen |
ヒダントイン誘導体
|
AU2010343102B2
(en)
|
2009-12-29 |
2016-03-24 |
Dana-Farber Cancer Institute, Inc. |
Type II Raf kinase inhibitors
|
AR080234A1
(es)
|
2010-02-25 |
2012-03-21 |
Marrone Bio Innovations Inc |
Cepa bacteriana aislada del genero burkholderia y metabolitos pesticidas del mismo
|
US8987275B2
(en)
|
2010-03-16 |
2015-03-24 |
Dana-Farber Cancer Institute, Inc. |
Indazole compounds and their uses
|
WO2011123609A1
(en)
|
2010-03-31 |
2011-10-06 |
Glaxo Group Limited |
Imidazolyl-imidazoles as kinase inhibitors
|
WO2011133964A2
(en)
|
2010-04-23 |
2011-10-27 |
Massachusetts Eye And Ear Infirmary |
Methods and compositions for preserving photoreceptor and retinal pigment epithelial cells
|
WO2012061045A2
(en)
|
2010-11-01 |
2012-05-10 |
Massachusetts Eye And Ear Infirmary |
Methods and compositions for preserving retinal ganglion cells
|
EP2683387A4
(en)
|
2011-03-07 |
2014-09-03 |
Univ Ohio State |
MUTATORY ACTIVITY INDUCED BY INFLAMMATION OF MICROARN-155 (MIR-155) BINDING AND CANCER
|
EP2707714B1
(en)
|
2011-05-09 |
2019-10-09 |
Whitehead Institute For Biomedical Research |
Chaperone interaction assays and uses thereof
|
CN102850252B
(zh)
|
2011-06-30 |
2014-08-13 |
山东大学 |
一种3,5,5’-三取代乙内酰脲的制备方法
|
WO2013013826A1
(en)
|
2011-07-27 |
2013-01-31 |
Friedrich-Alexander-Universität Erlangen-Nürnberg |
Necroptosis inhibitors for the treatment of inflammatory diseases of the gastrointestinal tract
|
US9314328B2
(en)
|
2011-08-16 |
2016-04-19 |
W. L. Gore & Associates, Inc. |
Branched stent graft device and deployment
|
KR101632806B1
(ko)
|
2011-08-27 |
2016-06-23 |
마론 바이오 이노베이션스, 인코포레이티드 |
부르크홀데리아 속의 단리된 박테리아 균주 및 그로부터의 살충 대사물-제제 및 용도
|
CA2888805C
(en)
|
2011-10-21 |
2020-07-14 |
Massachusetts Eye And Ear Infirmary |
Methods and compositions for promoting axon regeneration and nerve function
|
US8492556B2
(en)
|
2011-11-10 |
2013-07-23 |
Allergan, Inc. |
2,5-Dioxoimidazolidin-1-yl-3-phenylurea derivatives as formyl peptide receptor like-1 (FPRL-1) receptor modulators
|
JP6513019B2
(ja)
|
2012-05-04 |
2019-05-15 |
ノバルティス アーゲー |
Iapインヒビター治療のためのバイオマーカー
|
AU2013281396A1
(en)
|
2012-06-26 |
2015-02-05 |
Biovalence Sdn. Bhd. |
Anticancer treatment
|
WO2014008167A2
(en)
|
2012-07-02 |
2014-01-09 |
Cell Assay Innovations, Inc. |
Cell-based assays for post-translational enzyme activity
|
JPWO2014126127A1
(ja)
|
2013-02-13 |
2017-02-02 |
国立大学法人北海道大学 |
ネクロプトーシス関連疾患の治療用医薬組成物及びその有効成分のスクリーニング方法
|
TWI648274B
(zh)
|
2013-02-15 |
2019-01-21 |
英商葛蘭素史克智慧財產發展有限公司 |
作為激酶抑制劑之雜環醯胺類 (二)
|
EP2961849A2
(en)
|
2013-02-27 |
2016-01-06 |
The Broad Institute, Inc. |
T cell balance gene expression, compositions of matters and methods of use thereof
|
WO2014152182A1
(en)
*
|
2013-03-15 |
2014-09-25 |
President And Fellows Of Harvard College |
Deuterated heterocyclic inhibitors of necroptosis
|
US9725452B2
(en)
|
2013-03-15 |
2017-08-08 |
Presidents And Fellows Of Harvard College |
Substituted indoles and pyrroles as RIP kinase inhibitors
|
AU2014234400B2
(en)
|
2013-03-21 |
2017-11-16 |
Sanofi-Aventis Deutschland Gmbh |
Synthesis of hydantoin containing peptide products
|
EP2986317A4
(en)
|
2013-04-15 |
2016-10-05 |
Yeda Res & Dev |
INHIBITION OF RIP KINASES FOR THE TREATMENT OF LYSOSOMAL STORAGE DISEASES
|
GB201316651D0
(en)
|
2013-09-19 |
2013-11-06 |
Univ Southampton |
Asthma
|
EP3049836A1
(en)
|
2013-09-23 |
2016-08-03 |
Carl Zeiss SMT GmbH |
Multilayer mirror
|
EP2857839A1
(en)
|
2013-10-01 |
2015-04-08 |
AIT Austrian Institute of Technology GmbH |
Breast cancer diagnostic method and means
|
WO2015077709A2
(en)
|
2013-11-22 |
2015-05-28 |
World Biotechnology LLC |
Method for harvesting organic compounds from genetically modified organisms
|
WO2015105657A1
(en)
|
2013-12-19 |
2015-07-16 |
Ptc Therapeutics, Inc. |
Methods for modulating the amount of rna transcripts
|
WO2015095449A1
(en)
|
2013-12-19 |
2015-06-25 |
Ptc Therapeutics, Inc. |
Methods for modulating the amount rna transcripts
|
WO2015105938A1
(en)
|
2014-01-08 |
2015-07-16 |
World Biotechnology LLC |
Genetically modified organisms to produce organic compounds
|
WO2015154197A1
(en)
|
2014-04-11 |
2015-10-15 |
Children's Hospital Of Eastern Ontario Research Institute Inc. |
Compositions and methods for glioblastoma treatment
|
EP3180014A1
(en)
|
2014-08-13 |
2017-06-21 |
Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. |
Prevention of tumour metastasis by inhibition of necroptosis
|
JP6543342B2
(ja)
|
2014-08-14 |
2019-07-10 |
アルハマドシャー,マモウン,エム. |
血清半減期を延長するための、調節可能リンカーを介した薬学的活性剤とトランスサイレチンリガンドのコンジュゲーション
|
WO2016044777A1
(en)
|
2014-09-18 |
2016-03-24 |
Abbvie Inc. |
Hat inhibitors and methods for their use
|
EP3017825A1
(en)
|
2014-11-06 |
2016-05-11 |
Ludwig-Maximilians-Universität München |
An inhibitor of the RIPK1-dependent necrosis pathway and a pharmaceutical composition comprising the same
|
WO2016094846A1
(en)
|
2014-12-11 |
2016-06-16 |
President And Fellows Of Harvard College |
Inhibitors of cellular necrosis and related methods
|
EP3224237B1
(en)
|
2014-12-24 |
2024-09-11 |
National Institute Of Biological Sciences, Beijing |
Necrosis inhibitors
|
CN107108492B
(zh)
|
2014-12-24 |
2021-03-19 |
北京生命科学研究所 |
细胞坏死抑制剂
|